Human/Primate IL-2 Antibody Summary
Ala21-Thr153
Accession # NP_000577
Applications
Human/Primate IL-2 Sandwich Immunoassay
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
IL‑2 in Human PBMCs. IL-2 was detected in immersion fixed human peripheral blood mononuclear cells (PBMCs) stimulated with PMA and ionomycin using 10 µg/mL Mouse Anti-Human/Primate IL-2 Monoclonal Antibody (Catalog # MAB602) for 3 hours at room temperature. Cells were stained with the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-2
Interleukin-2 (IL-2) is a cytokine that stimulates the growth and differentiation of B cells, T cells, NK cells, and monocyte/macrophages. It functions through the heterotrimeric IL-2 receptor comprising alpha, beta, and gamma chains.
Product Datasheets
Citations for Human/Primate IL-2 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
31
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Hypothermic Ex Situ Perfusion of Human Limbs With Acellular Solution for 24 Hours
Authors: Valentin Haug, Branislav Kollar, Sotirios Tasigiorgos, Yori Endo, Martin Kauke, Ali-Farid Safi et al.
Transplantation
-
Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation
Authors: Karin Schilbach, Mohammed Alkhaled, Christian Welker, Franziska Eckert, Gregor Blank, Hendrik Ziegler et al.
OncoImmunology
-
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
Authors: Eleonora Trotta, Paul H. Bessette, Stephanie L. Silveria, Lauren K. Ely, Kevin M. Jude, Duy T. Le et al.
Nature Medicine
-
Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells
Authors: Carsten Krieg, Sven Létourneau, Giuseppe Pantaleo, Onur Boyman
Proceedings of the National Academy of Sciences
-
Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
Authors: Rodrigo Vazquez-Lombardi, Claudia Loetsch, Daniela Zinkl, Jennifer Jackson, Peter Schofield, Elissa K. Deenick et al.
Nature Communications
-
Ectopic Lymphoid Follicle Formation and Human Seasonal Influenza Vaccination Responses Recapitulated in an Organ‐on‐a‐Chip
Authors: Girija Goyal, Pranav Prabhala, Gautam Mahajan, Bruce Bausk, Tal Gilboa, Liangxia Xie et al.
Advanced Science
-
Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
Authors: Hussein Sultan, Takumi Kumai, Valentyna I. Fesenkova, Aaron E. Fan, Juan Wu, Hyun-Il Cho et al.
Cancer Immunology Research
-
Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation
Authors: Jason F. Kreisberg, Wes Yonemoto, Warner C. Greene
The Journal of Experimental Medicine
-
Canine Bone Marrow Derived Mesenchymal Stromal Cells Suppress Allo-Reactive Lymphocyte Proliferation in Vitro but Fail to Enhance Engraftment in Canine Bone Marrow Transplantation
Authors: Won Sik Lee, Yasuhiro Suzuki, Scott S. Graves, Mineo Iwata, G.M. Venkataraman, Marco Mielcarek et al.
Biology of Blood and Marrow Transplantation
-
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells
Authors: CJ Dwyer, DC Arhontouli, GO Rangel Riv, HM Knochelman, AS Smith, MM Wyatt, MP Rubinstein, C Atkinson, JE Thaxton, DM Neskey, CM Paulos
Eur. J. Immunol., 2020-05-28;0(0):.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo -
Heterogeneous GM-CSF signaling in macrophages is associated with control of Mycobacterium tuberculosis
Authors: BD Bryson, TR Rosebrock, FG Tafesse, CY Itoh, A Nibasumba, GH Babunovic, B Corleis, C Martin, C Keegan, P Andrade, S Realegeno, D Kwon, RL Modlin, SM Fortune
Nat Commun, 2019-05-27;10(1):2329.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
IL2/anti-IL2 complex combined with CTLA-4, but not PD-1, blockade rescues antitumor NK cell function by regulatory T-cell modulation
Authors: P Caudana, N Núñez, P DelaRocher, A Pinto, J Denizeau, R Alonso, L Niborski, O Lantz, C Sedlik, E Piaggio
Cancer Immunol Res, 2019-01-16;0(0):.
Species: Human
Sample Types: In Vivo
Applications: In Vivo -
Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology
Authors: SJ Whitfield, C Taylor, JE Risdall, GD Griffiths, JT Jones, ED Williamson, S Rijpkema, L Saraiva, S Vessillier, AC Green, AJ Carter
J. Immunol, 2017-03-20;0(0):.
Species: Human
Sample Types: Cell Culture Supernates
-
Key Residues at Third CDR3? Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs
Authors: Kenji Chamoto
J. Immunol, 2016-12-21;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: ELISA Development (Capture) -
Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes
Authors: Lauryn E. Klevorn, Melissa M. Berrien-Elliott, Jinyun Yuan, Lindsey M. Kuehm, Gregory D. Felock, Sean A. Crowe et al.
Cancer Immunology Research
Species: Xenograft
Sample Types: In Vivo
Applications: In vivo assay -
Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation
Authors: Karin Schilbach, Mohammed Alkhaled, Christian Welker, Franziska Eckert, Gregor Blank, Hendrik Ziegler et al.
OncoImmunology
Species: Transgenic Mouse
Sample Types: In Vivo
Applications: Neutralization -
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig.
Authors: Rochman Y, Yukawa M, Kartashov A, Barski A
PLoS ONE, 2015-04-10;10(4):e0122198.
Species: Human
Sample Types: Cell Culture Supernates
Applications: ELISA Development (Capture) -
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'.
Authors: Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L, Moraga I, Raeber ME, Bowman GR, Novick P, Pande VS, Fathman CG, Boyman O, Garcia KC
Nature, 2012-03-25;484(7395):529-33.
Species: Human
Sample Types: Recombinant Protein
Applications: Neutralization -
IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response.
Authors: Rubinstein MP, Lind NA, Purton JF, Filippou P, Best JA, McGhee PA, Surh CD, Goldrath AW
Blood, 2008-08-08;112(9):3704-12.
Species: Human
Sample Types: Recombinant Protein
Applications: Stimulation -
Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.
Authors: Biancotto A, Iglehart SJ, Lisco A, Vanpouille C, Grivel JC, Lurain NS, Reichelderfer PS, Margolis LB
AIDS Res. Hum. Retroviruses, 2008-03-01;24(3):453-62.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Luminex Development -
Effect of serum content and diluent selection on assay sensitivity and signal intensity in multiplex bead-based immunoassays.
Authors: Pfleger C, Schloot N, ter Veld F
J. Immunol. Methods, 2007-10-22;329(1):214-8.
Species: Human
Sample Types: Serum
Applications: Luminex Development -
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.
Authors: Biancotto A, Grivel JC, Iglehart SJ, Vanpouille C, Lisco A, Sieg SF, Debernardo R, Garate K, Rodriguez B, Margolis LB, Lederman MM
Blood, 2007-02-08;109(10):4272-9.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Luminex Development -
HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Authors: Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ, McGowan I, Margolis L, Anton P
AIDS, 2007;21(10):1263-72.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Luminex Development -
Th2 cytokine response in Major Depressive Disorder patients before treatment.
Authors: Kiryushko D, Pavon L, Novitskaya V, Sandoval-Lopez G, Soroka V, Eugenia Hernandez M, Klingelhofer J, Loria F, Lukanidin E, Estrada I, Berezin V, Perez M, Bock E, Moreno J, Avila U, Leff P, Anton B, Heinze G
J. Neuroimmunol., 2006-02-02;172(1):156-65.
Species: Human
Sample Types: Serum
Applications: ELISA Development -
Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4.
Authors: Farah IO, Mola PW, Kariuki TM, Nyindo M, Blanton RE, King CL
J. Immunol., 2000-05-15;164(10):5337-43.
Species: Primate - Papio anubis (Olive Baboon)
Sample Types: Cell Culture Supernates
Applications: ELISA Development -
IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25
Authors: Sven Létourneau, Ester M. M. van Leeuwen, Carsten Krieg, Chris Martin, Giuseppe Pantaleo, Jonathan Sprent et al.
Proceedings of the National Academy of Sciences
-
Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes
Authors: Lauryn E. Klevorn, Melissa M. Berrien-Elliott, Jinyun Yuan, Lindsey M. Kuehm, Gregory D. Felock, Sean A. Crowe et al.
Cancer Immunology Research
-
Ligation of the CD2 co-stimulatory receptor enhances IL-2 production from first-generation chimeric antigen receptor T cells
Authors: E J Cheadle, D G Rothwell, J S Bridgeman, V E Sheard, R E Hawkins, D E Gilham
Gene Therapy
-
Airplug‐Mediated Isolation and Centralization of Single T Cells in Rectangular Microwells for Biosensing
Authors: Pavithra Sukumar, Muhammedin Deliorman, Ayoola T. Brimmo, Roaa Alnemari, Deena Elsori, Weiqiang Chen et al.
Advanced Therapeutics
-
TCB2, a new anti-human interleukin-2 antibody, facilitates heterodimeric IL-2 receptor signaling and improves anti-tumor immunity
Authors: Jun-Young Lee, Eunjin Lee, Sung-Wook Hong, Daeun Kim, O. Eunju, Jonathan Sprent et al.
OncoImmunology
-
Multiplexed Protein Quantification with Barcoded Hydrogel Microparticles
Authors: David C. Appleyard, Stephen C. Chapin, Patrick S. Doyle
Analytical Chemistry
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human/Primate IL-2 Antibody
Average Rating: 5 (Based on 2 Reviews)
Have you used Human/Primate IL-2 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
